10 Best Undervalued Stocks for November 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The current market environment presents a compelling opportunity for value-focused investors seeking exposure to quality companies trading at attractive valuations. Our selection methodology emphasizes companies with strong fundamental metrics, including robust free cash flow generation, healthy return on invested capital (ROIC), and reasonable debt levels relative to equity.[1][2]
This curated watchlist spans multiple sectors—semiconductors, software, healthcare, financial services, and automotive—providing meaningful diversification while maintaining focus on businesses with sustainable competitive advantages. Each stock has been evaluated using ValueSense's proprietary intrinsic value calculator, which combines discounted cash flow analysis with relative valuation metrics to identify securities trading at meaningful discounts to their calculated fair value.[1]
Featured Stock Analysis
Stock #1: Taiwan Semiconductor Manufacturing Company Limited (TSM)
| Metric | Value |
|---|---|
| Market Cap | $1,558.3B |
| Quality Rating | 8.2 |
| Intrinsic Value | $415.7 |
| 1Y Return | 58.1% |
| Revenue | NT$3,631.4B |
| Free Cash Flow | NT$889.9B |
| Revenue Growth | 37.0% |
| FCF margin | 24.5% |
| Gross margin | 59.0% |
| ROIC | 36.2% |
| Total Debt to Equity | 19.0% |
Investment Thesis
Taiwan Semiconductor Manufacturing Company (TSMC) represents a compelling semiconductor play for investors seeking exposure to the artificial intelligence infrastructure buildout. With a market cap of $1,558.3B and a quality rating of 8.2—among the highest in this watchlist—TSMC demonstrates exceptional operational efficiency and capital returns. The company's intrinsic value of $415.7 suggests meaningful upside potential, while the 1-year return of 58.1% reflects strong recent momentum driven by AI chip demand.[1]
TSMC's financial metrics underscore its competitive moat and operational excellence. The company generated revenue of NT$3,631.4B with an impressive 37.0% revenue growth rate, demonstrating accelerating demand for advanced semiconductor manufacturing. Most notably, TSMC's free cash flow margin of 24.5% and gross margin of 59.0% showcase the company's ability to convert sales into cash while maintaining pricing power. The return on invested capital of 36.2% is exceptional, indicating that management deploys capital with remarkable efficiency. With a total debt-to-equity ratio of 19.0%, TSMC maintains a conservative balance sheet while generating substantial returns.
Key Catalysts
- Continued AI chip demand from major cloud providers and technology companies
- Advanced node capacity expansion to support next-generation semiconductor requirements
- Potential geopolitical tailwinds from semiconductor supply chain diversification initiatives
- Strong free cash flow generation supporting potential dividend increases and shareholder returns
Risk Factors
- Geopolitical tensions affecting Taiwan and cross-strait relations
- Cyclical semiconductor industry dynamics and potential demand normalization
- Significant capital expenditure requirements to maintain technological leadership
- Concentration risk from major customer dependencies
Stock #2: Micron Technology, Inc. (MU)
| Metric | Value |
|---|---|
| Market Cap | $249.7B |
| Quality Rating | 8.4 |
| Intrinsic Value | $368.6 |
| 1Y Return | 124.8% |
| Revenue | $37.4B |
| Free Cash Flow | $8,929.0M |
| Revenue Growth | 48.9% |
| FCF margin | 23.9% |
| Gross margin | 39.8% |
| ROIC | 15.9% |
| Total Debt to Equity | 27.2% |
Investment Thesis
Micron Technology presents an aggressive growth opportunity within the semiconductor sector, with a quality rating of 8.4 and exceptional recent performance. The company's 1-year return of 124.8% reflects strong investor recognition of its positioning in memory chip markets critical to AI infrastructure. Trading at an intrinsic value of $368.6, Micron's market cap of $249.7B positions it as a significant player in DRAM and NAND flash memory production.[1]
The company's financial trajectory demonstrates powerful momentum. Revenue of $37.4B grew at an impressive 48.9% year-over-year, indicating robust demand for memory solutions across data centers and consumer applications. Micron's free cash flow margin of 23.9% and gross margin of 39.8% reflect healthy profitability despite the capital-intensive nature of semiconductor manufacturing. The ROIC of 15.9% demonstrates solid capital efficiency, while the debt-to-equity ratio of 27.2% remains manageable for a cyclical industry player.
Key Catalysts
- Accelerating AI data center buildout driving demand for high-bandwidth memory (HBM) and advanced DRAM
- Potential price recovery in NAND flash memory markets as supply-demand dynamics normalize
- New manufacturing capacity coming online to capture market share growth
- Strategic partnerships with major cloud and AI infrastructure providers
Risk Factors
- Cyclical industry dynamics with potential for memory price compression
- Significant capital expenditure requirements for competitive positioning
- Concentration of demand among major cloud providers
- Technology transition risks as industry moves to next-generation memory architectures
Stock #3: Berkshire Hathaway Inc. (BRK-B)
| Metric | Value |
|---|---|
| Market Cap | $1,030.9B |
| Quality Rating | 6.0 |
| Intrinsic Value | $645.0 |
| 1Y Return | 5.9% |
| Revenue | $370.2B |
| Free Cash Flow | $8,225.0M |
| Revenue Growth | 0.0% |
| FCF margin | 2.2% |
| Gross margin | 24.2% |
| ROIC | 11.3% |
| Total Debt to Equity | 19.0% |
Investment Thesis
Berkshire Hathaway offers a diversified holding company structure with a quality rating of 6.0 and a market cap of $1,030.9B. The company's intrinsic value of $645.0 suggests potential upside, though the 1-year return of 5.9% reflects a more conservative positioning compared to growth-oriented technology stocks. Berkshire's portfolio approach provides exposure to insurance, utilities, manufacturing, and financial services, offering meaningful diversification benefits.[1]
The company generated revenue of $370.2B with a free cash flow of $8,225.0M, demonstrating substantial cash generation capabilities. While revenue growth of 0.0% reflects the company's mature scale, the free cash flow margin of 2.2% and gross margin of 24.2% indicate efficient operations across diverse business segments. The ROIC of 11.3% reflects solid capital deployment, while the debt-to-equity ratio of 19.0% maintains financial flexibility for opportunistic investments.
Key Catalysts
- Potential deployment of substantial cash reserves ($167+ billion) into attractive acquisition or investment opportunities
- Insurance underwriting profits benefiting from higher interest rate environment
- Utility business growth and regulated returns providing stable cash flows
- Potential special dividends or share buybacks at attractive valuations
Risk Factors
- Succession planning uncertainties following leadership transitions
- Mature business model limiting explosive growth potential
- Concentration in insurance and financial services sectors
- Potential regulatory changes affecting insurance and utility operations
Stock #4: Alibaba Group Holding Limited (BABA)
| Metric | Value |
|---|---|
| Market Cap | $393.8B |
| Quality Rating | 6.2 |
| Intrinsic Value | $471.6 |
| 1Y Return | 73.9% |
| Revenue | CN¥1,000.8B |
| Free Cash Flow | CN¥25.9B |
| Revenue Growth | 5.3% |
| FCF margin | 2.6% |
| Gross margin | 41.2% |
| ROIC | 15.8% |
| Total Debt to Equity | 21.2% |
Investment Thesis
Alibaba represents a compelling China-focused technology opportunity with a quality rating of 6.2 and a market cap of $393.8B. The company's intrinsic value of $471.6 suggests meaningful upside potential, while the exceptional 1-year return of 73.9% reflects strong recovery from previous lows. Alibaba's diversified business model spanning e-commerce, cloud computing, and digital media provides multiple growth vectors.[1]
The company generated revenue of CN¥1,000.8B with a gross margin of 41.2%, demonstrating pricing power across its platform ecosystem. Revenue growth of 5.3% reflects stabilization following previous regulatory headwinds, while the free cash flow margin of 2.6% indicates improving cash generation. The ROIC of 15.8% demonstrates solid capital returns, and the debt-to-equity ratio of 21.2% maintains reasonable financial flexibility.
Key Catalysts
- Chinese economic stimulus measures supporting consumer spending and e-commerce growth
- Cloud computing business expansion capturing enterprise digital transformation demand
- International expansion opportunities in Southeast Asia and emerging markets
- Potential regulatory clarity supporting investor confidence in Chinese technology stocks
Risk Factors
- Ongoing regulatory scrutiny from Chinese government authorities
- Macroeconomic headwinds affecting Chinese consumer spending
- Competitive pressures from domestic e-commerce and cloud competitors
- Geopolitical tensions affecting U.S.-China technology relations
Stock #5: SAP SE (SAP)
| Metric | Value |
|---|---|
| Market Cap | $303.4B |
| Quality Rating | 6.4 |
| Intrinsic Value | $303.0 |
| 1Y Return | 11.3% |
| Revenue | €36.5B |
| Free Cash Flow | €6,482.0M |
| Revenue Growth | 9.7% |
| FCF margin | 17.8% |
| Gross margin | 73.5% |
| ROIC | 16.6% |
| Total Debt to Equity | 21.1% |
Investment Thesis
SAP represents a high-quality enterprise software opportunity with a quality rating of 6.4 and a market cap of $303.4B. The company's intrinsic value of $303.0 suggests fair valuation with potential for appreciation as the business model transitions to cloud-based recurring revenue. The 1-year return of 11.3% reflects steady appreciation as investors recognize the company's transformation progress.[1]
SAP generated revenue of €36.5B with an impressive gross margin of 73.5%, reflecting the high-margin nature of software and cloud services. Revenue growth of 9.7% demonstrates consistent expansion, while the free cash flow margin of 17.8% indicates strong cash conversion. The ROIC of 16.6% demonstrates efficient capital deployment, and the debt-to-equity ratio of 21.1% maintains financial stability.
Key Catalysts
- Continued cloud migration driving recurring subscription revenue growth
- Enterprise AI adoption creating demand for intelligent business applications
- Margin expansion as cloud revenue mix increases
- Strategic partnerships and acquisitions supporting competitive positioning
Risk Factors
- Competitive pressures from cloud-native competitors and Microsoft
- Legacy on-premise business decline as customers migrate to cloud
- Execution risks in cloud transition strategy
- Macroeconomic sensitivity affecting enterprise software spending
Stock #6: Salesforce, Inc. (CRM)
| Metric | Value |
|---|---|
| Market Cap | $249.0B |
| Quality Rating | 6.9 |
| Intrinsic Value | $270.9 |
| 1Y Return | -10.5% |
| Revenue | $39.5B |
| Free Cash Flow | $12.5B |
| Revenue Growth | 8.3% |
| FCF margin | 31.6% |
| Gross margin | 77.6% |
| ROIC | 10.8% |
| Total Debt to Equity | 4.6% |
Investment Thesis
Salesforce offers exposure to cloud-based customer relationship management and enterprise software with a quality rating of 6.9 and a market cap of $249.0B. The company's intrinsic value of $270.9 suggests modest upside potential, while the 1-year return of -10.5% reflects recent market volatility. Salesforce's market leadership in CRM and expanding portfolio of cloud applications position it well for enterprise digital transformation trends.[1]
The company generated revenue of $39.5B with an exceptional gross margin of 77.6%, demonstrating the high-margin profile of cloud software businesses. Revenue growth of 8.3% reflects steady expansion, while the free cash flow margin of 31.6% indicates excellent cash conversion and operational efficiency. The ROIC of 10.8% demonstrates solid capital returns, and the debt-to-equity ratio of 4.6% reflects a conservative balance sheet with significant financial flexibility.
Key Catalysts
- AI integration across Salesforce platform driving customer value and retention
- Expansion into adjacent markets through organic development and acquisitions
- International market penetration opportunities
- Potential margin expansion as cloud revenue mix increases
Risk Factors
- Competitive pressures from Microsoft, Oracle, and specialized CRM competitors
- Customer concentration risks among large enterprise accounts
- Execution risks in product integration and AI strategy
- Macroeconomic sensitivity affecting enterprise software spending
Stock #7: Cisco Systems, Inc. (CSCO)
| Metric | Value |
|---|---|
| Market Cap | $289.5B |
| Quality Rating | 6.6 |
| Intrinsic Value | $78.2 |
| 1Y Return | 34.4% |
| Revenue | $56.7B |
| Free Cash Flow | $13.3B |
| Revenue Growth | 5.3% |
| FCF margin | 23.5% |
| Gross margin | 65.1% |
| ROIC | 13.3% |
| Total Debt to Equity | 63.3% |
Investment Thesis
Cisco represents a mature technology infrastructure play with a quality rating of 6.6 and a market cap of $289.5B. The company's intrinsic value of $78.2 suggests significant upside potential, while the 1-year return of 34.4% reflects strong recent performance. Cisco's diversified networking, security, and collaboration portfolio positions it to benefit from enterprise digital transformation and cybersecurity spending.[1]
The company generated revenue of $56.7B with a gross margin of 65.1%, reflecting the profitable nature of networking and software solutions. Revenue growth of 5.3% demonstrates steady expansion, while the free cash flow margin of 23.5% indicates strong cash generation. The ROIC of 13.3% demonstrates solid capital efficiency, though the debt-to-equity ratio of 63.3% reflects higher leverage compared to pure software peers.
Key Catalysts
- Cybersecurity spending acceleration driving demand for integrated security solutions
- Cloud and hybrid infrastructure adoption supporting networking equipment demand
- Software and subscription revenue growth improving recurring revenue mix
- Potential dividend increases and share buybacks supported by strong cash flow
Risk Factors
- Competitive pressures from specialized networking and security vendors
- Transition from hardware to software-centric business model execution risks
- Macroeconomic sensitivity affecting enterprise IT spending
- Potential disruption from emerging networking technologies
Stock #8: UnitedHealth Group Incorporated (UNH)
| Metric | Value |
|---|---|
| Market Cap | $310.1B |
| Quality Rating | 6.2 |
| Intrinsic Value | $598.9 |
| 1Y Return | -39.3% |
| Revenue | $435.2B |
| Free Cash Flow | $17.4B |
| Revenue Growth | 11.8% |
| FCF margin | 4.0% |
| Gross margin | 19.7% |
| ROIC | 19.0% |
| Total Debt to Equity | 78.9% |
Investment Thesis
UnitedHealth Group presents a healthcare services opportunity with a quality rating of 6.2 and a market cap of $310.1B. The company's intrinsic value of $598.9 suggests substantial upside potential, while the 1-year return of -39.3% reflects recent market challenges. UnitedHealth's diversified healthcare platform spanning insurance, pharmacy benefits, and healthcare services positions it to benefit from aging demographics and healthcare spending growth.[1]
The company generated revenue of $435.2B with a gross margin of 19.7%, reflecting the competitive nature of healthcare services. Revenue growth of 11.8% demonstrates strong expansion, while the free cash flow margin of 4.0% indicates cash generation despite operational complexity. The ROIC of 19.0% demonstrates solid capital returns, though the debt-to-equity ratio of 78.9% reflects higher leverage typical of healthcare services companies.
Key Catalysts
- Aging U.S. population driving growth in healthcare services demand
- Operational efficiency improvements and cost management initiatives
- Potential regulatory clarity supporting investor confidence
- Strategic acquisitions and partnerships expanding service capabilities
Risk Factors
- Regulatory pressures affecting healthcare reimbursement rates
- Cybersecurity risks given access to sensitive healthcare data
- Competitive pressures from other healthcare insurers and providers
- Macroeconomic sensitivity affecting healthcare utilization patterns
Stock #9: AbbVie Inc. (ABBV)
| Metric | Value |
|---|---|
| Market Cap | $386.4B |
| Quality Rating | 6.1 |
| Intrinsic Value | $286.5 |
| 1Y Return | 8.0% |
| Revenue | $58.3B |
| Free Cash Flow | $18.2B |
| Revenue Growth | 6.1% |
| FCF margin | 31.3% |
| Gross margin | 74.3% |
| ROIC | 12.6% |
| Total Debt to Equity | (51,073.2%) |
Investment Thesis
AbbVie offers exposure to the pharmaceutical and healthcare products sector with a quality rating of 6.1 and a market cap of $386.4B. The company's intrinsic value of $286.5 suggests upside potential, while the 1-year return of 8.0% reflects steady appreciation. AbbVie's diversified pharmaceutical portfolio and strong free cash flow generation position it well for income-focused investors.[1]
The company generated revenue of $58.3B with an exceptional gross margin of 74.3%, reflecting the high-margin nature of pharmaceutical products. Revenue growth of 6.1% demonstrates steady expansion, while the free cash flow margin of 31.3% indicates excellent cash conversion and operational efficiency. The ROIC of 12.6% demonstrates solid capital returns, supporting the company's substantial dividend payments.
Key Catalysts
- Blockbuster drug portfolio supporting consistent revenue generation
- Potential new product launches and pipeline advancement
- International market expansion opportunities
- Dividend growth and shareholder return programs
Risk Factors
- Patent expiration risks affecting key revenue drivers
- Regulatory pressures on pharmaceutical pricing
- Research and development execution risks
- Competitive pressures from generic and biosimilar manufacturers
Stock #10: Toyota Motor Corporation (TM)
| Metric | Value |
|---|---|
| Market Cap | $266.1B |
| Quality Rating | 6.3 |
| Intrinsic Value | $477.3 |
| 1Y Return | 18.0% |
| Revenue | ¥48.5T |
| Free Cash Flow | ¥44.4B |
| Revenue Growth | 4.5% |
| FCF margin | 0.1% |
| Gross margin | 19.3% |
| ROIC | 8.0% |
| Total Debt to Equity | 103.9% |
Investment Thesis
Toyota represents a global automotive leader with a quality rating of 6.3 and a market cap of $266.1B. The company's intrinsic value of $477.3 suggests meaningful upside potential, while the 1-year return of 18.0% reflects strong recent performance. Toyota's diversified vehicle portfolio, hybrid technology leadership, and strong balance sheet position it well within the automotive industry transition.[1]
The company generated revenue of ¥48.5T with a gross margin of 19.3%, reflecting competitive dynamics in the automotive sector. Revenue growth of 4.5% demonstrates steady expansion, while the free cash flow margin of 0.1% indicates tight cash conversion typical of capital-intensive manufacturing. The ROIC of 8.0% reflects moderate capital efficiency, and the debt-to-equity ratio of 103.9% reflects higher leverage common in automotive manufacturing.
Key Catalysts
- Hybrid vehicle demand growth as consumers seek fuel efficiency
- Electric vehicle portfolio expansion capturing EV market growth
- Autonomous driving technology development and commercialization
- Strong brand recognition and customer loyalty supporting pricing power
Risk Factors
- Intense competition from traditional and emerging EV manufacturers
- Supply chain disruptions affecting production and profitability
- Transition risks from internal combustion to electric vehicles
- Macroeconomic sensitivity affecting consumer vehicle demand
Portfolio Diversification Insights
This curated watchlist provides meaningful sector diversification across technology, healthcare, and industrials. The semiconductor exposure through TSM and MU captures the artificial intelligence infrastructure buildout, while software positions in SAP and CRM provide enterprise digital transformation exposure. Healthcare representation through UNH and ABBV offers defensive characteristics and dividend income potential, while automotive exposure through Toyota provides cyclical balance.
The portfolio quality ratings range from 6.0 to 8.4, with the highest-rated positions (TSM and MU) representing semiconductor leaders positioned to benefit from structural AI demand growth. The diversification across geographies—including U.S., Taiwan, China, and Japan—provides international exposure while maintaining focus on quality businesses with strong fundamentals.
Free cash flow generation across the portfolio averages approximately 15-20% of revenue for software and semiconductor companies, with lower conversion rates for capital-intensive businesses like automotive and healthcare services. This cash generation capability supports dividend payments, share buybacks, and strategic investments, providing multiple return pathways for investors.
Market Timing & Entry Strategies
The current market environment presents a compelling opportunity for value-focused investors seeking exposure to quality businesses at reasonable valuations. Rather than attempting to time market movements, consider implementing a dollar-cost averaging strategy across this watchlist, deploying capital over 3-6 months to reduce timing risk and capture potential volatility.
For technology and semiconductor positions (TSM, MU, SAP, CRM, CSCO), consider building positions on any market weakness, as these companies demonstrate strong fundamental momentum and competitive positioning. The recent 1-year returns for TSM 58.1% and MU 124.8% reflect strong investor recognition, but the intrinsic value calculations suggest continued upside potential.
Healthcare and diversified positions (UNH, ABBV, BRK-B) may benefit from a more patient accumulation approach, given recent volatility in healthcare stocks and the defensive characteristics of these businesses. The significant discount between UNH's intrinsic value $598.9 and recent trading levels presents a compelling entry opportunity for long-term investors.
For international positions (BABA, TM), consider the geopolitical and macroeconomic factors affecting these markets. Alibaba's recent 73.9% 1-year return reflects recovery from previous lows, while Toyota's 18.0% return suggests steady appreciation. Both positions offer exposure to important growth markets with reasonable valuations.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- How VKTX (Viking Therapeutics) Makes Money in 2025: A Deep-Dive With Income Statement
- How NET (Cloudflare) Makes Money in 2025: A Deep-Dive With Income Statement
- How MASS (908 Devices) Makes Money in 2025: A Deep-Dive With Income Statement
- How CRVO (CervoMed) Makes Money in 2025: A Deep-Dive With Income Statement
- How GILD (Gilead Sciences) Makes Money in 2025: A Deep-Dive With Income Statement
FAQ Section
Q1: How were these stocks selected for this watchlist?
These stocks were selected using ValueSense's proprietary intrinsic value calculator, which combines discounted cash flow analysis with relative valuation metrics to identify securities trading at meaningful discounts to calculated fair value.[1] The selection emphasizes companies with strong fundamental metrics including robust free cash flow generation, healthy return on invested capital, and reasonable debt levels. The portfolio provides meaningful diversification across sectors, geographies, and business models while maintaining focus on quality businesses with sustainable competitive advantages.
Q2: Which stock from this list offers the best risk-adjusted opportunity?
Taiwan Semiconductor Manufacturing Company (TSM) and Micron Technology (MU) demonstrate the highest quality ratings (8.2 and 8.4 respectively) combined with strong fundamental metrics and growth trajectories. TSM's 36.2% ROIC and 59.0% gross margin reflect exceptional operational efficiency, while MU's 48.9% revenue growth demonstrates powerful momentum in memory chip markets. For more conservative investors, Berkshire Hathaway (BRK-B) offers diversified exposure with lower volatility, though at the expense of growth potential.
Q3: Should I invest in all these stocks or focus on specific positions?
The optimal approach depends on your investment objectives, risk tolerance, and time horizon. For diversified exposure, consider building positions across multiple sectors—semiconductors (TSM, MU), software (SAP, CRM, CSCO), healthcare (UNH, ABBV), and diversified holdings (BRK-B). For growth-focused portfolios, concentrate on semiconductor and software positions. For income-focused strategies, emphasize healthcare and diversified positions with strong dividend histories. Consider implementing a dollar-cost averaging strategy to reduce timing risk.
Q4: What are the biggest risks with these stock picks?
Sector-specific risks include semiconductor cyclicality and geopolitical tensions affecting Taiwan (TSM), healthcare regulatory pressures affecting reimbursement rates (UNH, ABBV), and automotive industry transition risks (TM). Macroeconomic sensitivity affects enterprise software spending (SAP, CRM, CSCO) and consumer discretionary demand (BABA, TM). Geopolitical tensions affect Chinese technology stocks (BABA) and Taiwan-based manufacturers (TSM). Individual company risks include competitive pressures, execution risks in strategic transitions, and customer concentration. Diversification across this watchlist helps mitigate individual company risks.
Q5: When is the best time to invest in these stocks?
Rather than attempting to time market movements, implement a systematic approach through dollar-cost averaging over 3-6 months to reduce timing risk and capture potential volatility. For technology and semiconductor positions showing strong momentum (TSM, MU), consider building positions on any market weakness. For healthcare and diversified positions (UNH, ABBV, BRK-B), employ a patient accumulation approach given defensive characteristics. Monitor ValueSense's intrinsic value calculations and earnings analysis to identify optimal entry points when stocks trade at meaningful discounts to calculated fair value.[1][2]